Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dowling, C. Articles by Vigneron, D. B. Search for Related Content PubMed PubMed Citation Articles by Dowling, C. Articles by Vigneron, D. B.

American Journal of Neuroradiology 22:604-612 (4 2001)
© 2001 American Society of Neuroradiology

ARTICLE

Preoperative Proton MR Spectroscopic Imaging of Brain Tumors: Correlation with Histopathologic Analysis of Resection Specimens

Chris Dowling^a, Andrew W. Bollen^a, Susan M. Noworolski^a, Michael W. McDermott^a, Nicholas M. Barbaro^a, Mark R. Day^a, Roland G. Henry^a, Susan M. Chang^a, William P. Dillon^a, Sarah J. Nelson^a and Daniel B. Vigneron^,a

^a From the Departments of Radiology (C.D., S.M.N., M.R.D., R.G.H., W.P.D., S.J.N., D.B.V.), Pathology (A.W.B.), and Neurological Surgery (M.W.M., N.M.B., S.MC.), University of California, San Francisco.

BACKGROUND AND PURPOSE: Tumor progression is often difficult to distinguish from nonneoplastic treatment response on the basis of MR images alone. This study correlates metabolite levels measured by preoperative MR spectroscopic (MRS) imaging with histologic findings of biopsies, obtained during image-guided resections of brain mass lesions, to clarify the potential role of MRS in making this distinction.

METHODS: Twenty-nine patients with brain tumors underwent high-resolution (0.2–1 cc) 3D proton MRS imaging and MR imaging before undergoing surgery; 11 had a newly diagnosed neoplasm, and 18 had recurrent disease. Surgical biopsies were obtained from locations referenced on MR images by guidance with a surgical navigation system. MR spectral voxels were retrospectively centered on each of 79 biopsy locations, and metabolite levels were correlated with histologic examination of each specimen.

RESULTS: All mass lesions studied, whether attributable to tumor or noncancerous effects of previous therapy, showed abnormal MR spectra compared with normal parenchyma. When the pattern of MRS metabolites consisted of abnormally increased choline and decreased N-acetyl aspartate (NAA) resonances, histologic findings of the biopsy specimen invariably was positive for tumor. When choline and NAA resonances were below the normal range, histologic findings were variable, ranging from radiation necrosis, astrogliosis, and macrophage infiltration to mixed tissues that contained some low-, intermediate-, and high-grade tumor.

CONCLUSION: This study demonstrated that 3D MRS imaging can identify regions of viable cancer, which may be valuable for guiding surgical biopsies and focal therapy. Regions manifesting abnormal MR spectra had a mixture of histologic findings, including astrogliosis, necrosis, and neoplasm.

This article has been cited by other articles:

				L.S. Hu, L.C. Baxter, K.A. Smith, B.G. Feuerstein, J.P. Karis, J.M. Eschbacher, S.W. Coons, P. Nakaji, R.F. Yeh, J. Debbins, et al. Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 552 - 558. [Abstract] [Full Text] [PDF]

				C. Majos, C. Aguilera, J. Alonso, M. Julia-Sape, S. Castaner, J.J. Sanchez, A. Samitier, A. Leon, A. Rovira, and C. Arus Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 544 - 551. [Abstract] [Full Text] [PDF]

				E. A. Smith, R. C. Carlos, L. R. Junck, C. I. Tsien, A. Elias, and P. C. Sundgren Developing a Clinical Decision Model: MR Spectroscopy to Differentiate Between Recurrent Tumor and Radiation Change in Patients with New Contrast-Enhancing Lesions Am. J. Roentgenol., February 1, 2009; 192(2): W45 - W52. [Abstract] [Full Text] [PDF]

				J. L. Spratlin, N. J. Serkova, and S. G. Eckhardt Clinical Applications of Metabolomics in Oncology: A Review Clin. Cancer Res., January 15, 2009; 15(2): 431 - 440. [Abstract] [Full Text] [PDF]

				P.H. Lai, H.H. Weng, C.Y. Chen, S.S. Hsu, S. Ding, C.W. Ko, J.H. Fu, H.L. Liang, and K.H. Chen In Vivo Differentiation of Aerobic Brain Abscesses and Necrotic Glioblastomas Multiforme Using Proton MR Spectroscopic Imaging AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1511 - 1518. [Abstract] [Full Text] [PDF]

				A. C Peet, T. N Arvanitis, D. P Auer, N. P Davies, D. Hargrave, F. A Howe, T. Jaspan, M. O Leach, D. Macarthur, L. MacPherson, et al. The value of magnetic resonance spectroscopy in tumour imaging Arch. Dis. Child., September 1, 2008; 93(9): 725 - 727. [Full Text] [PDF]

				B. J. Pichler, H. F. Wehrl, and M. S. Judenhofer Latest Advances in Molecular Imaging Instrumentation J. Nucl. Med., June 1, 2008; 49(Suppl_2): 5S - 23S. [Abstract] [Full Text] [PDF]

				C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]

				R. N. Al-Okaili, J. Krejza, J. H. Woo, R. L. Wolf, D. M. O'Rourke, K. D. Judy, H. Poptani, and E. R. Melhem Intraaxial Brain Masses: MR Imaging-based Diagnostic Strategy--Initial Experience Radiology, May 1, 2007; 243(2): 539 - 550. [Abstract] [Full Text] [PDF]

				M. V. Spampinato, J. K. Smith, L. Kwock, M. Ewend, J. D. Grimme, D. L. A. Camacho, and M. Castillo Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors Am. J. Roentgenol., January 1, 2007; 188(1): 204 - 212. [Abstract] [Full Text] [PDF]

				M. A. Weber, S. Zoubaa, M. Schlieter, E. Juttler, H. B. Huttner, K. Geletneky, C. Ittrich, M. P. Lichy, A. Kroll, J. Debus, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors Neurology, June 27, 2006; 66(12): 1899 - 1906. [Abstract] [Full Text] [PDF]

				Y. Cao, P. C. Sundgren, C. I. Tsien, T. T. Chenevert, and L. Junck Physiologic and Metabolic Magnetic Resonance Imaging in Gliomas J. Clin. Oncol., March 10, 2006; 24(8): 1228 - 1235. [Abstract] [Full Text] [PDF]

				N. A. Butowski, P. K. Sneed, and S. M. Chang Diagnosis and Treatment of Recurrent High-Grade Astrocytoma J. Clin. Oncol., March 10, 2006; 24(8): 1273 - 1280. [Abstract] [Full Text] [PDF]

				A. Stadlbauer, S. Gruber, C. Nimsky, R. Fahlbusch, T. Hammen, R. Buslei, B. Tomandl, E. Moser, and O. Ganslandt Preoperative Grading of Gliomas by Using Metabolite Quantification with High-Spatial-Resolution Proton MR Spectroscopic Imaging Radiology, March 1, 2006; 238(3): 958 - 969. [Abstract] [Full Text] [PDF]

				B. A. Cohen, E. A. Knopp, H. Rusinek, J. S. Babb, D. Zagzag, and O. Gonen Assessing Global Invasion of Newly Diagnosed Glial Tumors with Whole-Brain Proton MR Spectroscopy AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2170 - 2177. [Abstract] [Full Text] [PDF]

				C. Nimsky, O. Ganslandt, B. von Keller, J. Romstock, and R. Fahlbusch Intraoperative High-Field-Strength MR Imaging: Implementation and Experience in 200 Patients Radiology, October 1, 2004; 233(1): 67 - 78. [Abstract] [Full Text] [PDF]

				K. E. Warren NMR Spectroscopy and Pediatric Brain Tumors Oncologist, June 1, 2004; 9(3): 312 - 318. [Abstract] [Full Text] [PDF]

				K. Vuori, L. Kankaanranta, A.-M. Hakkinen, E. Gaily, L. Valanne, M.-L. Granstrom, H. Joensuu, G. Blomstedt, A. Paetau, and N. Lundbom Low-Grade Gliomas and Focal Cortical Developmental Malformations: Differentiation with Proton MR Spectroscopy Radiology, March 1, 2004; 230(3): 703 - 708. [Abstract] [Full Text] [PDF]

				M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF]

				P. D. Brown, J. T. Wald, M. W. McDermott, G. S. Baumann, and T. F. Cloughesy Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningioma. RadioGraphics, November 1, 2003; 23(6): 1591 - 1611. [Full Text] [PDF]

				S. J. Nelson Multivoxel Magnetic Resonance Spectroscopy of Brain Tumors Mol. Cancer Ther., May 1, 2003; 2(5): 497 - 507. [Abstract] [Full Text] [PDF]

				N. Bulakbasi, M. Kocaoglu, F. Ors, C. Tayfun, and T. Ucoz Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 225 - 233. [Abstract] [Full Text] [PDF]

				W.-C. Wu, C.-Y. Chen, H.-W. Chung, C.-J. Juan, C.-J. Hsueh, and H.-W. Gao Discrepant MR Spectroscopic and Perfusion Imaging Results in a Case of Malignant Transformation of Cerebral Glioma AJNR Am. J. Neuroradiol., November 1, 2002; 23(10): 1775 - 1778. [Abstract] [Full Text] [PDF]

				M. Law, S. Cha, E. A. Knopp, G. Johnson, J. Arnett, and A. W. Litt High-Grade Gliomas and Solitary Metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging Radiology, March 1, 2002; 222(3): 715 - 721. [Abstract] [Full Text] [PDF]

				S. Cha, E. A. Knopp, G. Johnson, S. G. Wetzel, A. W. Litt, and D. Zagzag Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging Radiology, April 1, 2002; 223(1): 11 - 29. [Abstract] [Full Text] [PDF]